Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Research

Use of complementary and alternative medicine by cancer patients in Colombia

Authors: Raúl Murillo, Nidia Pinto-Martínez, Norma Serrano, Claudia Uribe, Edgar Navarro, Jorge Duque, Andrés Yepes, Laura Olaya, Carolina Mariño, Olga Lucia Morales, Marcela Andrea Erazo-Muñoz, Diana Carolina Sánchez-Vega, Nicolás Martínez-Ramos

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

The use of complementary and alternative medicines (CAM) among cancer patients varies greatly. The available data suggest an increasing use of CAM over time and a higher prevalence in low- and middle-income countries. However, no reliable data are available from Latin America. Accordingly, we examined the prevalence of CAM use among cancer patients from six Colombian regions.

Methods

We conducted a survey on cancer patients attending comprehensive cancer centres in six capital cities from different regions. The survey was designed based on a literature review and information gathered through focus groups on CAM terminology in Colombia. Independent random samples of patients from two comprehensive cancer centres in every city were obtained. Patients 18 years and older with a histopathological diagnosis of cancer undergoing active treatment were eligible. The prevalence of CAM use is reported as a percentage with the corresponding confidence interval. CAM types are reported by region. The sociodemographic and clinical characteristics of CAM users and non-users were compared using Chi square and t tests.

Results

In total, 3117 patients were recruited. The average age 59.6 years old, and 62.8% were female. The prevalence of CAM use was 51.7%, and compared to non-users, CAM users were younger, more frequently women, affiliated with the health insurance plan for low-income populations and non-Catholic. We found no differences regarding the clinical stage or treatment modality, but CAM users reported more treatment-related side effects. The most frequent types of CAM were herbal products, specific foods and vitamins, and individually, soursop was the most frequently used product. Relevant variability between regions was observed regarding the prevalence and type of CAM used (range: 36.6% to 66.7%). The most frequent reason for using CAM was symptom management (30.5%), followed by curative purposes (19.5%).

Conclusions

The prevalence of CAM use among cancer patients in Colombia is high in general, and variations between regions might be related to differences in cultural backgrounds and access to comprehensive cancer care. The most frequently used CAM products and practices have little scientific support, suggesting the need to enhance integrative oncology research in the country.
Appendix
Available only for authorised users
Literature
1.
go back to reference Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P, et al. A Comprehensive Definition for Integrative Oncology. J Natl Cancer Inst Monogr. 2017;2017(52):lgx012. Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P, et al. A Comprehensive Definition for Integrative Oncology. J Natl Cancer Inst Monogr. 2017;2017(52):lgx012.
2.
go back to reference Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: a systematic review. Complement Ther Clin Pract. 2019;35:33–47.CrossRefPubMed Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: a systematic review. Complement Ther Clin Pract. 2019;35:33–47.CrossRefPubMed
3.
go back to reference Truant TL, Porcino AJ, Ross BC, Wong ME, Hilario CT. Complementary and alternative medicine (CAM) use in advanced cancer: a systematic review. J Support Oncol. 2013;11(3):105–13.CrossRefPubMed Truant TL, Porcino AJ, Ross BC, Wong ME, Hilario CT. Complementary and alternative medicine (CAM) use in advanced cancer: a systematic review. J Support Oncol. 2013;11(3):105–13.CrossRefPubMed
4.
go back to reference Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187–203.CrossRefPubMed Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187–203.CrossRefPubMed
5.
go back to reference Hill J, Mills C, Li Q, Smith JS. Prevalence of traditional, complementary, and alternative medicine use by cancer patients in low income and lower-middle income countries. Glob Public Health. 2019;14(3):418–30.CrossRefPubMed Hill J, Mills C, Li Q, Smith JS. Prevalence of traditional, complementary, and alternative medicine use by cancer patients in low income and lower-middle income countries. Glob Public Health. 2019;14(3):418–30.CrossRefPubMed
6.
go back to reference Nigenda G, Mora-Flores G, Aldama-Lopez S, Orozco-Nunez E. Practice of traditional medicine in Latin America and the Caribbean: the dilemma between regulation and tolerance. Salud Publica Mex. 2001;43(1):41–51.CrossRefPubMed Nigenda G, Mora-Flores G, Aldama-Lopez S, Orozco-Nunez E. Practice of traditional medicine in Latin America and the Caribbean: the dilemma between regulation and tolerance. Salud Publica Mex. 2001;43(1):41–51.CrossRefPubMed
7.
go back to reference Guido PC, Ribas A, Gaioli M, Quattrone F, Macchi A. The state of the integrative medicine in Latin America: the long road to include complementary, natural, and traditional practices in formal health systems. Eur J Integr Med. 2014;7:5–12.CrossRef Guido PC, Ribas A, Gaioli M, Quattrone F, Macchi A. The state of the integrative medicine in Latin America: the long road to include complementary, natural, and traditional practices in formal health systems. Eur J Integr Med. 2014;7:5–12.CrossRef
8.
go back to reference Moral-Munoz JA, Carballo-Costa L, Herrera-Viedma E, Cobo MJ. Production trends, collaboration, and main topics of the integrative and complementary oncology research area: a bibliometric analysis. Integr Cancer Ther. 2019;18:1534735419846401.CrossRefPubMedPubMedCentral Moral-Munoz JA, Carballo-Costa L, Herrera-Viedma E, Cobo MJ. Production trends, collaboration, and main topics of the integrative and complementary oncology research area: a bibliometric analysis. Integr Cancer Ther. 2019;18:1534735419846401.CrossRefPubMedPubMedCentral
9.
go back to reference Danell JB. Integrative oncology from a bibliometric point of view. Complement Ther Med. 2020;52:102477.CrossRefPubMed Danell JB. Integrative oncology from a bibliometric point of view. Complement Ther Med. 2020;52:102477.CrossRefPubMed
10.
go back to reference Ladas EJ, Rivas S, Ndao D, Damoulakis D, Bao YY, Cheng B, et al. Use of traditional and complementary/alternative medicine (TCAM) in children with cancer in Guatemala. Pediatr Blood Cancer. 2014;61(4):687–92.CrossRefPubMed Ladas EJ, Rivas S, Ndao D, Damoulakis D, Bao YY, Cheng B, et al. Use of traditional and complementary/alternative medicine (TCAM) in children with cancer in Guatemala. Pediatr Blood Cancer. 2014;61(4):687–92.CrossRefPubMed
11.
go back to reference Idoyaga-Molina A, Luxardo N. Medicinas no convencionales en cáncer. Medicina (Buenos Aires). 2005;65:390–4. Idoyaga-Molina A, Luxardo N. Medicinas no convencionales en cáncer. Medicina (Buenos Aires). 2005;65:390–4.
12.
go back to reference Balneaves LG, Watling CZ, Hayward EN, Ross B, Taylor-Brown J, Porcino A, et al. Addressing complementary and alternative medicine use among individuals with cancer: an integrative review and clinical practice guideline. J Natl Cancer Inst. 2022;114(1):25–37.CrossRefPubMed Balneaves LG, Watling CZ, Hayward EN, Ross B, Taylor-Brown J, Porcino A, et al. Addressing complementary and alternative medicine use among individuals with cancer: an integrative review and clinical practice guideline. J Natl Cancer Inst. 2022;114(1):25–37.CrossRefPubMed
13.
go back to reference Geck MS, Cristians S, Berger-Gonzalez M, Casu L, Heinrich M, Leonti M. Traditional herbal medicine in mesoamerica: toward its evidence base for improving universal health coverage. Front Pharmacol. 2020;11:1160.CrossRefPubMedPubMedCentral Geck MS, Cristians S, Berger-Gonzalez M, Casu L, Heinrich M, Leonti M. Traditional herbal medicine in mesoamerica: toward its evidence base for improving universal health coverage. Front Pharmacol. 2020;11:1160.CrossRefPubMedPubMedCentral
14.
go back to reference Delgado-Lopez PD, Corrales-Garcia EM. Influence of Internet and Social Media in the Promotion of Alternative Oncology, Cancer Quackery, and the Predatory Publishing Phenomenon. Cureus. 2018;10(5):e2617.PubMedPubMedCentral Delgado-Lopez PD, Corrales-Garcia EM. Influence of Internet and Social Media in the Promotion of Alternative Oncology, Cancer Quackery, and the Predatory Publishing Phenomenon. Cureus. 2018;10(5):e2617.PubMedPubMedCentral
16.
go back to reference Uribe Parra D, Pulido Martinez DC, De Vries E. Access to diagnostic facilities in children with cancer in Colombia: Spotting opportunity and distance from a sample. Cancer Epidemiol. 2020;64:101645.CrossRefPubMed Uribe Parra D, Pulido Martinez DC, De Vries E. Access to diagnostic facilities in children with cancer in Colombia: Spotting opportunity and distance from a sample. Cancer Epidemiol. 2020;64:101645.CrossRefPubMed
17.
go back to reference Costo CdA. Situación del cáncer en población adulta atendida en el SGSSS de Colombia 2021. Bogotá: CAC; 2022. Costo CdA. Situación del cáncer en población adulta atendida en el SGSSS de Colombia 2021. Bogotá: CAC; 2022.
18.
go back to reference Sánchez R, Venegas M. Aproximaciones complementarias y alternativas al cuidado de la salud en el Instituto Nacional de Cancerología: estudio de prevalencia. Revista Colombiana de Cancerología. 2010;14(3):135–43.CrossRef Sánchez R, Venegas M. Aproximaciones complementarias y alternativas al cuidado de la salud en el Instituto Nacional de Cancerología: estudio de prevalencia. Revista Colombiana de Cancerología. 2010;14(3):135–43.CrossRef
19.
go back to reference Murcia E, Aguilera J, Wiesner C, Pardo C. Oncology services supply in Colombia. Colomb Med (Cali). 2018;49(1):89–96.PubMed Murcia E, Aguilera J, Wiesner C, Pardo C. Oncology services supply in Colombia. Colomb Med (Cali). 2018;49(1):89–96.PubMed
20.
go back to reference García-Padilla P, Ordóñez Reyes C, Medina P, Fernández Deaza G, Morales OL, Murillo R. Perspectivas de pacientes y profesionales en torno al uso de medicinas alternativas y complementarias para el cuidado del cáncer: un estudio exploratorio. Universitas Medica. 2021;62(1):1–12. García-Padilla P, Ordóñez Reyes C, Medina P, Fernández Deaza G, Morales OL, Murillo R. Perspectivas de pacientes y profesionales en torno al uso de medicinas alternativas y complementarias para el cuidado del cáncer: un estudio exploratorio. Universitas Medica. 2021;62(1):1–12.
21.
go back to reference Wieland LS, Manheimer E, Berman BM. Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med. 2011;17(2):50.PubMedPubMedCentral Wieland LS, Manheimer E, Berman BM. Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med. 2011;17(2):50.PubMedPubMedCentral
22.
go back to reference Lopez G, Salas CA, Cadiz F, Barriga C, Gonzalez P, Acevedo S, et al. Complementary and integrative medicine use in individuals seeking conventional medical oncology care in Chile: prevalence and patient characteristics. J Glob Oncol. 2019;5:1–6.PubMed Lopez G, Salas CA, Cadiz F, Barriga C, Gonzalez P, Acevedo S, et al. Complementary and integrative medicine use in individuals seeking conventional medical oncology care in Chile: prevalence and patient characteristics. J Glob Oncol. 2019;5:1–6.PubMed
23.
go back to reference Molina I, Luxardo N. Medicinas no convencionales en cáncer. Medicina (Buenos Aires). 2005;65(5):390–4. Molina I, Luxardo N. Medicinas no convencionales en cáncer. Medicina (Buenos Aires). 2005;65(5):390–4.
24.
go back to reference Gavamukulya Y, Wamunyokoli F, El-Shemy HA. Annona muricata: Is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects. Asian Pac J Trop Med. 2017;10(9):835–48.CrossRefPubMed Gavamukulya Y, Wamunyokoli F, El-Shemy HA. Annona muricata: Is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects. Asian Pac J Trop Med. 2017;10(9):835–48.CrossRefPubMed
25.
go back to reference Cruceriu D, Balacescu O, Rakosy E. Calendula officinalis: potential roles in cancer treatment and palliative care. Integr Cancer Ther. 2018;17(4):1068–78.CrossRefPubMedPubMedCentral Cruceriu D, Balacescu O, Rakosy E. Calendula officinalis: potential roles in cancer treatment and palliative care. Integr Cancer Ther. 2018;17(4):1068–78.CrossRefPubMedPubMedCentral
26.
go back to reference Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, et al. Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998–4024.CrossRefPubMed Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, et al. Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998–4024.CrossRefPubMed
27.
go back to reference Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647–55.CrossRefPubMed Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647–55.CrossRefPubMed
28.
go back to reference Mao JJ, Pillai GG, Andrade CJ, Ligibel JA, Basu P, Cohen L, et al. Integrative oncology: addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144–64.CrossRefPubMed Mao JJ, Pillai GG, Andrade CJ, Ligibel JA, Basu P, Cohen L, et al. Integrative oncology: addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144–64.CrossRefPubMed
29.
go back to reference Tangkiatkumjai M, Boardman H, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther. 2020;20(1):363.CrossRefPubMedPubMedCentral Tangkiatkumjai M, Boardman H, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther. 2020;20(1):363.CrossRefPubMedPubMedCentral
Metadata
Title
Use of complementary and alternative medicine by cancer patients in Colombia
Authors
Raúl Murillo
Nidia Pinto-Martínez
Norma Serrano
Claudia Uribe
Edgar Navarro
Jorge Duque
Andrés Yepes
Laura Olaya
Carolina Mariño
Olga Lucia Morales
Marcela Andrea Erazo-Muñoz
Diana Carolina Sánchez-Vega
Nicolás Martínez-Ramos
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-04144-z

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue